Labetalol dosage forms and strengths

Revision as of 15:20, 5 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Labetalol}} {{CMG}}; {{AE}} {{SS}} ==dosage forms and strengths(injection, solution)== {| |- |thumb|800px |- |}<ref name="dailymed.nlm.nih.gov">...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Labetalol
LABETALOL tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
LABETALOL injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Labetalol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

dosage forms and strengths(injection, solution)

[1]


dosage forms and strengths(tablet, film coated )


[1]


References

  1. ↑ 1.0 1.1 "LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.]". Retrieved 5 February 2014.

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Labetalol_dosage_forms_and_strengths&oldid=938686"